Corcept Therapeutics Inc (CORT) operating KPIs
CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 11/30408% above fair value
$81.12−4.83 (-5.62%)
Close on Oct 30, 2026Market cap $8.77BP/E 193.1Yield –
KPIs
Operating metrics that drive Corcept Therapeutics's business
Coming soon
This tab will track the numbers specific to Corcept Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.